Literature DB >> 25448943

Computational and spectral studies of 6-phenylazo-3-(p-tolyl)-2H-chromen-2-one.

A Manimekalai1, N Vijayalakshmi2.   

Abstract

6-Phenylazo-3-(p-tolyl)-2H-chromen-2-one 4 was prepared and characterized by IR, (1)H, and (13)C NMR spectral studies. The optimized structure of the chromen-2-one 4 was investigated by the Gaussian 03 B3LYP density functional method calculations at 6-31G(d,p) basis set. The gauge-independent atomic orbital (GIAO) (13)C and (1)H chemical shift calculations for the synthesized chromen-2-one in CDCl3 were also made by the same method. The computed IR frequencies of the chromen-2-one and the corresponding vibrational assignments were analyzed by means of potential energy distribution (PED%) calculation using vibrational energy distribution analysis (VEDA) program. The first order hyperpolarizability (βtot), polarizability (α) and dipole moment (μ) were calculated using 6-311G(d,p) basis set and the nonlinear optical (NLO) properties are also addressed theoretically. Stability of the chromen-2-one 4 molecule has been analyzed by calculating the intramolecular charge transfer using natural bond order (NBO) analysis. The molecular electrostatic potentials, HOMO-LUMO energy gap and geometrical parameters were also computed. Topological properties of the electronic charge density in chromen-2-one 4 were analyzed employing the Bader's Atoms in Molecule (AIM) theory which indicated the presence of intramolecular hydrogen bond in the molecule.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AIM; Chromen-2-one; DFT; VEDA

Mesh:

Substances:

Year:  2014        PMID: 25448943     DOI: 10.1016/j.saa.2014.09.045

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Coumarin Push-Pull NLOphores with Red Emission: Solvatochromic and Theoretical Approach.

Authors:  Sandip K Lanke; Nagaiyan Sekar
Journal:  J Fluoresc       Date:  2016-03-14       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.